Please login to the form below
genomics
This page shows the latest genomics news and features for those working in and with pharma, biotech and healthcare.
Moderna to acquire OriCiro Genomics for $85m
Moderna has announced it will acquire Japan-based DNA supplier OriCiro Genomics K.K (OriCiro) for $85m, marking the US company’s first acquisition since its 2010 launch.
Latest news
-
Genomics England receives government funding for cutting-edge genomics research
Genomics England will lead three initiatives aiming to advance the delivery of genomic healthcare to patients, following the announcement of a £175m funding boost from the UK Government. ... A Genomics England-led programme will also involve the
-
Alzheimer’s Research UK welcomes government’s recommitment to dementia mission
The new national mission is set to build on recent advances in biological and data sciences, including genomics, artificial intelligence and the latest brain imaging technology, in order to test new
-
FDA approves first gene therapy for adults with haemophilia B
Matt Kapusta, chief executive officer of uniQure, also said the approval represented a “major milestone in the field of genomic medicine and ushers in a new treatment paradigm for patients living
-
Verge Genomics begins human trials with AI-sourced ALS drug
VRG50635 was discovered by the company’s all-in-human, AI-powered platform. Verge Genomics (Verge) has announced that the first subject has been dosed in its phase 1 clinical trial ... Alice Zhang, chief executive officer of Verge Genomics, said: “We
-
ICR study raises possibility of predicting drug resistance in advance
Study leader Chris Lord, professor of cancer genomics at the ICR, London, said the discovery could “lay the groundwork for future clinical trials to test out new drug combinations and other
More from news
Approximately 27 fully matching, plus 193 partially matching documents found.
Latest Intelligence
-
Patient-centricity and how HCPs can help achieve better patient outcomes through collaboration
5. Rework – Genomics England is currently working on initiatives to ensure genetic testing is done correctly to reduce the need for patients to return for a second biopsy.
-
How early-stage clinical research is facilitating the new wave of personalised medicines
This is being progressed through the NHS Genomic Medicine Service which builds on the work of Genomics England to routinely offer NHS patients access to molecular and genomic testing. ... This investment in genomic technology and research, plus the
-
The promise of precision medicine
In Qatar, research into genomics and precision medicine is being used to tackle diseases such as obesity, diabetes and cardiovascular disease. ... Meanwhile, clinicians in the United States have been increasingly using genomic insights to inform their
-
AI and accelerated computing ring in new era for healthcare
of chemical structures, in-silico methods for screening, protein-ligand interactions, genomic analysis, and assimilating data from structured and unstructured sources. ... Genomic analyses can provide invaluable insights for researchers, helping them
-
Rare genetic diseases – what’s in store for 2021?
Understanding of genetics and DNA has come a long way, with labs around the world now using an individual’s genomic information to understand that individual’s risk of specific diseases ... We may be able to firmly establish genomic profiling to
More from intelligence
Approximately 8 fully matching, plus 51 partially matching documents found.
Latest appointments
-
Mark Caulfield departs from Genomics England to take on CEO role at Barts Life Sciences
Caulfield served as chief scientist at Genomics England, working on the 100, 000 Genomes Project. ... He was awarded a knighthood in 2019 following the project’s ‘unprecedented success’, Genomics England said in a statement.
-
BMS appoints new commercial leader, Davies joins Eisai and more
Congenica poaches AZ’s business performance director. Currently director of business performance at AstraZeneca, Wendy Britten (pictured) has decided to join Cambridge, UK-based Cogenica, a clinical genomics interpretation software provider.
-
Editas Medicine names James Mullen as chairman
Jim’s extensive experience in driving excellence across R&D, commercialisation, manufacturing, business development and capital formation will be invaluable as we continue to build a genomic medicine leader and develop
-
Global Gene Corp appoints new chief data and technology officer
Cambridge, UK-based genomics platform group Global Gene Corp (GGC), has appointed Dr Yaron Turpaz as its new chief data and technology officer, and managing director of the group’s Singapore ... I am looking forward to our journey together to create
-
Decibel Therapeutics expands leadership team
genomic technologies.
More from appointments
Approximately 3 fully matching, plus 20 partially matching documents found.
Latest from PMHub
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
As part of our commitment to the field of advanced therapies, emotive recently met with Genomics England, the masterminds behind the 100, 000 Genomes Project, to find out more.
-
Personalized Oncology: Calling for a New Kind of Partnership:
We need mathematicians and engineers, too. Frankly, biomarker research tends attract biologists interested in areas such as genomics and proteomics rather than engineers.
-
Pharmacogenomics supports and new era of precision medicine
While the two terms still can be used interchangeably in some settings, pharmacogenomics (the combined study of pharmacology – drugs – and genomics – genes) is a part of precision medicine, and allows us
-
Advancing Precision Medicine in Oncology
He also dives into the promises and pitfalls of genomic testing and precision medicine in oncology, and gives his take on how to build authentic relationships with oncology KOLs during and
-
How whole genome sequencing is revolutionising the rare disease patient experience
To make genomics a part of routine healthcare. To uncover answers or even new diagnoses for the participants in the study. ... Accessed June 8, 2022. Wilde S. The Newborn Genomes Programme: Genomics England answers your questions.
More from PMHub
Approximately 12 fully matching, plus 23 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- Europe’s cancer community publishes new report on transforming patient care
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Eli Lilly’s Alzheimer’s drug denied FDA accelerated approval
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- EU outlines measures to mitigate antibiotic shortage across Europe
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Merging global and local pharmacovigilance operations into a successful integrated approach
PMHub
Collected Group
Collected Group is a forward thinking healthcare communication company that supports biopharma and diagnostic companies to engage in more lasting...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
